Improved treatment of neovascularization
The use of an anti-angiogenic drug selected from inhibitors of protein kinase C, inhibitors of growth hormone and IGF-1 inhibitors of vascular endothelial growth factor, inhibitors of cyclooxygenase II, inhibitors of NF-kappa B, and PLA2 antagonists in conjunction with a photosensitive agent in the...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | The use of an anti-angiogenic drug selected from inhibitors of protein kinase C, inhibitors of growth hormone and IGF-1 inhibitors of vascular endothelial growth factor, inhibitors of cyclooxygenase II, inhibitors of NF-kappa B, and PLA2 antagonists in conjunction with a photosensitive agent in the preparation of a medicament for photodynamic treatment of unwanted neovasculature due to CNV (choroidal neovascularization) in a subject. |
|---|